1 / 81

Connective Tissue Diseases of the Skin

Connective Tissue Diseases of the Skin. MBChB IV. Outcomes for this lecture. After this lecture the student should be able to: Recognise and describe scleroderma Recognise and describe the different types of scleroderma

curt
Télécharger la présentation

Connective Tissue Diseases of the Skin

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Connective Tissue Diseases of the Skin MBChB IV

  2. Outcomes for this lecture • After this lecture the student should be able to: • Recognise and describe scleroderma • Recognise and describe the different types of scleroderma • Recognise and describe the symptoms and signs of systemic sclerosis (cutaneous and systemic) • Name and apply the investigations that has to be done in cases of scleroderma (clinical, side room tests, imaging and laboratory tests) • Broadly name the management of scleroderma • Recognise and describe in detail the clinical presentation of chronic discoid lupus erythematosus (DLE) • Broadly describe the management of DLE • Be aware of the condition named subacute cutaneous lupus erythematosus • Recognise and describe in detail the skin signs of acute systemic lupus erythematosus (SLE) • Name the systemic involvement of SLE and recognise and describe the symptoms and signs of systemic involvement • Name the serological tests that may be done to further investigate SLE and discuss the implications thereof • Name the special investigations (imaging and laboratory tests) that have to be done to investigate SLE • Describe in broad terms the management of SLE • Recognise and describe the clinical presentation of dermatomyositis (skin and muscle) • Recognise and describe the clinical presentation of cutaneous vasculitis and rheumatoid nodules

  3. Connective Tissue Diseases with Skin Lesions • Lupus erythematosus • Scleroderma • Dermatomyositis • Rheumatoid arthritis • Reiter’s syndrome

  4. Scleroderma • Variants • In common: Fibrosis / sclerosis of dermis Cutaneous vascular insufficiency • Sometimes systemic fibrosis

  5. Variants of Scleroderma • Systemic sclerosis • CREST • Morphoea • Pseudoscleroderma – porphyria lipodermatosclerosis

  6. Systemic Sclerosis • Raynaud’s phenomenon • Sclerodactyly • Diffuse scleroderma • Small oral orifice • Sharp tip of nose • Telangiectasia • Calcification Plus: Arthritis, esophageal dysmotility, lung fibrosis, hypertension, etc

  7. CREST • Calcifications (forearms) • Raynaud’s phenomenon • Esophageal dysmotility • Sclerodactyly • Telangiectasia By definition: No other systemic involvement

  8. Morphoea • Localised plaques of scleroderma • Seldom systemic involvement • Begins as pink-purple macule • Later central induration / hardening • Violaceus edge persists • Epidermis sometimes shiny, atrophic, depigmented, spotty • Sometimes deep atrophy

  9. Variants of Morphoea • Usual plaques (one or many) • Liniar / segmental • Central forehead (en coup de sabre) • Hemifacial involvement

  10. Further Examination • Skin lesions – helps to predict prognosis • Signs of arthritis • Blood pressure • Signs of lung fibrosis • Urine microscopy

  11. Special Investigations • Serology: ANF, ENAs Anti-Scl-70 • FBC • Renal functions • Chest X-rays • Lung functions • Barium swallow • Skin biopsy

  12. Management: Therapeutic • Vasodilators – prazocin nifedipine • Corticosteroids systemically – early • PUVA • NSAIDS • Cimetidine / PPIs • Chloroquine • Methotrexate • Cyclosporine A

  13. Management: Referral • Rheumatology • Nephrology

  14. Management: Advice / Information • Warn that blood pressure control is crucial • Minimize cold exposure • Soft diet if dysphagia present

  15. Management: Follow-up • Regularly – 3 monthly • Ask about arthralgia, dysphagia, dyspnea • Measure blood pressure • Tests urine • Lung functions

  16. Lupus Erythematosus • Chronic (Discoid LE) • Subacute LE • Systemic LE

  17. Discoid LE • Most common • Extremely chronic and resistant, mutilating • Photo areas • 5% Systemic involvement • Early diagnosis crucial

  18. Discoid LE • Erythema • Deep induration / firmness • Hyperkeratotic scaling • Follicular plugs • Atrophy • Edge of hyperpigmentation (grey, black) • Hair loss (scarring) • Cheilitis

  19. Discoid LE: Management • Sun protection • Topical steroids (potent) • Chloroquine • Exclude systemic involvement

  20. Subacute Cutaneous LE • Photosensitive disease • Face, shoulders, back, arms • Annular / psoriasiforme • Little / no atrophy • ENAs positive (anti-Ro, anti-La) • Arthritis • Brain -, lung involvement, not nephropathy

More Related